Compare Ryanair Holdings plc (RYAAY) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ryanair Holdings plc vs State Street SPDR S&P Biotech ETF — how do they compare? Ryanair Holdings plc trades at $58.99 (market cap $29.31B), while State Street SPDR S&P Biotech ETF trades at $154.42. The key difference: Ryanair Holdings plc pays a 1.68% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Ryanair Holdings plc nearer its low. Which is the better fit depends on your goals.
| RYAAY | XBI | |
|---|---|---|
Market Cap | $29.31B | — |
Sector | Industrials | Broad Market / Factor |
52-Week High | $73.82 | $164.28 |
52-Week Low | $53.24 | $85.16 |
Enterprise Value | $26.33B | — |
Dividend Yield | 1.68% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ryanair Holdings plc
Ryanair is the leading airline group by passenger numbers in Europe. The company employs a low-cost no-frills model to offer low fares to leisure customers on short-haul intra-European routes. In 2020, the most recent pre-pandemic fiscal year, the company carried 149 million passengers, utilizing a fleet of 467 Boeing 737 aircraft across its 1,800 routes. To keep costs low the company serves predominantly lower-cost secondary airports. The company generated sales of EUR 8.5 billion in fiscal 2020.
Read more on RYAAY →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
